BIONET Corp. (TPEX: 1784)
Taiwan
· Delayed Price · Currency is TWD
80.50
+1.00 (1.26%)
Jan 2, 2025, 1:30 PM CST
BIONET Revenue
BIONET had revenue of 303.91M TWD in the quarter ending September 30, 2024, with 5.07% growth. This brings the company's revenue in the last twelve months to 1.18B, up 6.60% year-over-year. In the year 2023, BIONET had annual revenue of 1.13B with 14.99% growth.
Revenue (ttm)
1.18B
Revenue Growth
+6.60%
P/S Ratio
3.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.13B | 146.93M | 14.99% |
Dec 31, 2022 | 980.38M | 58.96M | 6.40% |
Dec 31, 2021 | 921.42M | 114.85M | 14.24% |
Dec 31, 2020 | 806.58M | 31.02M | 4.00% |
Dec 31, 2019 | 775.56M | 4.95M | 0.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 49.98M |
Lotus Pharmaceutical | 17.59B |
Oneness Biotech | 112.20M |
Lumosa Therapeutics | 37.82M |
Polaris Group | 75.65M |
Center Laboratories | 1.57B |
Pegavision | 7.06B |